Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study

Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study

Abstract Objectives Iguratimod, a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective against murine lupus. The aim of this study was to make a preliminary evaluation of the efficacy and safety of iguratimod as salvage therapy in patients with refractory lupus nephr...

Full description

Bibliographic Details
Main Authors: Yuening Kang, Qingran Yan, Qiong Fu, Ran Wang, Min Dai, Fang Du, Qing Dai, Ping Ye, Chunmei Wu, Liangjing Lu, Chunde Bao
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Arthritis Research & Therapy
Subjects:
Iguratimod
Refractory lupus nephritis
Induction therapy
Online Access:http://link.springer.com/article/10.1186/s13075-020-02154-7

Similar Items

Similar Items